首页> 外文会议> >AN INTEGRATED IMAGE QUANTIFICATION SYSTEM FOR COLORECTAL CANCER RISK ASSESSMENT USING QUANTUM DOTS AND MOLECULAR PROFILING
【24h】

AN INTEGRATED IMAGE QUANTIFICATION SYSTEM FOR COLORECTAL CANCER RISK ASSESSMENT USING QUANTUM DOTS AND MOLECULAR PROFILING

机译:基于量子点和分子轮廓的大肠癌风险评估综合图像量化系统

获取原文

摘要

Colorectal cancer, the second leading cause of cancer deaths in the United States, is a disease for which there are no known biomarkers of risk that can be used for predicting and preventing the disease. Based on new knowledge of the molecular basis of colorectal cancer, we developed and validated a panel of biomarkers of risk that can be measured in rectal biopsies. The goal of this work is to develop an integrated detection and image analysis quantification system for measuring and applying these biomarkers in clinical research and care. More importantly, the new system can process biopsy images from both traditional and bionanotechnology quantum dot-based IHC, and through a combination of novel and automated image analysis and quantification algorithms, it will significantly reduce processing time by detecting multiple biomarkers simultaneously on the same histologic sections. Clinical application of this novel process of detecting and quantifying biomarkers, coupled with decision support from the analysis of a biomarker quantification database, is expected to open new frontiers in the field of colorectal cancer prognosis and treatment.
机译:结直肠癌是美国癌症死亡的第二大主要原因,是一种尚无可用于预测和预防该疾病的已知风险生物标志物的疾病。基于对结直肠癌分子基础的新认识,我们开发并验证了一组可以在直肠活检中测量的风险生物标志物。这项工作的目标是开发一个集成的检测和图像分析量化系统,以在临床研究和护理中测量和应用这些生物标记物。更重要的是,该新系统可以处理来自传统和基于生物纳米技术的基于量子点的IHC的活检图像,并且通过结合新颖的自动图像分析和定量算法,它将通过在同一组织学上同时检测多个生物标志物来显着减少处理时间。部分。这种检测和定量生物标志物的新方法的临床应用,再加上对生物标志物定量数据库的分析提供的决策支持,有望在结直肠癌预后和治疗领域开辟新的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号